| The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression |
35 |
| Effect of antidepressant treatment on peripheral inflammation markers - A meta-analysis |
30 |
| PSD95: A synaptic protein implicated in schizophrenia or autism? |
27 |
| Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis |
26 |
| Chronic pain and suicide risk: A comprehensive review |
26 |
| Differentiating between bipolar and unipolar depression in functional and structural MRI studies |
26 |
| The Dynamic Duo: Combining noninvasive brain stimulation with cognitive interventions |
24 |
| Dendritic spines: Revisiting the physiological role |
22 |
| Transdiagnostic and diagnosis-specific dynamic functional connectivity anchored in the right anterior insula in major depressive disorder and bipolar depression |
21 |
| Evaluating psychosocial contributions to chronic pain outcomes |
21 |
| Side effect burden of antipsychotic drugs in real life - Impact of gender and polypharmacy |
21 |
| Epidemiology of pain and relation to psychiatric disorders |
18 |
| The intersection of stress and reward: BNST modulation of aversive and appetitive states |
17 |
| Translocator protein (18 kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy |
16 |
| Cortical thickness in major depressive disorder: A systematic review and meta-analysis |
16 |
| The anti-inflammatory mechanism of antidepressants - SSRIs, SNRIs |
16 |
| Toward biomarkers of the addicted human brain: Using neuroimaging to predict relapse and sustained abstinence in substance use disorder |
16 |
| Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis |
15 |
| Glutamatergic synapses in neurodevelopmental disorders |
15 |
| Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review |
15 |
| Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease |
15 |
| The role of the orbitofrontal cortex in alcohol use, abuse, and dependence |
15 |
| A review on inflammatory cytokine-induced alterations of the brain as potential neural biomarkers in post-traumatic stress disorder |
14 |
| Gender does not matter: Add-on repetitive transcranial magnetic stimulation treatment for female methamphetamine dependents |
14 |
| Chronic pain and pain processing in Parkinson's disease |
14 |
| Cytokine alterations and cognitive impairment in major depressive disorder: From putative mechanisms to novel treatment targets |
14 |
| IDO chronic immune activation and tryptophan metabolic pathway: A potential pathophysiological link between depression and obesity |
14 |
| Linking the biological underpinnings of depression: Role of mitochondria interactions with melatonin, inflammation, sirtuins, tryptophan catabolites, DNA repair and oxidative and nitrosative stress, with consequences for classification and cognition |
14 |
| Abnormal segments of right uncinate fasciculus and left anterior thalamic radiation in major and bipolar depression |
14 |
| Modeling consequences of prolonged strong unpredictable stress in zebrafish: Complex effects on behavior and physiology |
14 |
| Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa |
14 |
| The silent epidemic of chronic pain in older adults |
14 |
| Protective role of Apelin-13 on amyloid beta 25-35-induced memory deficit; Involvement of autophagy and apoptosis process |
14 |
| The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions |
14 |
| Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts |
13 |
| Prenatal ethanol induces an anxiety phenotype and alters expression of dynorphin & nociceptin/orphanin FQ genes |
13 |
| The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
13 |
| Meta-analyses of the functional neural alterations in subjects with Internet gaming disorder: Similarities and differences across different paradigms |
13 |
| Trying to make sense of rodents' drug choice behavior |
13 |
| The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials |
13 |
| Glucocorticoids, genes and brain function |
13 |
| Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione |
13 |
| Neurometabolite levels in antipsychotic-naive/free patients with schizophrenia: A systematic review and meta-analysis of H-1-MRS studies |
12 |
| Pain and consciousness |
12 |
| Sleep, chronic pain, and opioid risk for apnea |
12 |
| MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms? |
12 |
| Altered neuro-inflammatory gene expression in hippocampus in major depressive disorder |
12 |
| Therapeutic effect of adjunctive N-acetyl cysteine (NAC) on symptoms of chronic schizophrenia: A double-blind, randomized clinical trial |
12 |
| Pharmacogenetic tests to guide drug treatment in depression: Comparison of the available testing kits and clinical trials |
12 |
| The brain's spontaneous activity and its psychopathological symptoms - Spatiotemporal binding and integration |
12 |
